Hodnocení pětileté léčby Erdheimovy-Chesterovy nemoci anakinrou – kazuistika a přehled literatury

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Title in English Evaluation of five years of treatment of Erdheim-Chester disease with anakinra: case report and overview of literature
Authors

ADAM Zdeněk PETRÁŠOVÁ Hana ŘEHÁK Zdeněk KOUKALOVÁ Renata KREJČÍ Marta POUR Luděk VETEŠNÍKOVÁ Eva ČERMÁK Aleš ŠEVČÍKOVÁ Sabina SZTURZ Petr MAYER Jiří

Year of publication 2016
Type Article in Periodical
Magazine / Source Vnitřní lékařství
MU Faculty or unit

Faculty of Medicine

Citation
Field Oncology and hematology
Keywords anakinra; Erdheim-Chester disease
Description Erdheim-Chester disease is a histiocytic neoplasm of diseases from the group of non-Langerhans-cell histiocyto-ses, formed by infiltrates of foamy histiocytes. These pathological histiocytes produce pro-inflammatory cytokines. Therefore Erdheim-Chester disease is called inflammatory histiocytary neoplasm. The disease is accompanied by clinical symptoms of systemic inflammatory response, i.e. B symptoms. Imaging examinations detect typical osteo-sclerotic changes affecting diaphyses and metaphyses of the lower long bones and fibrotic changes which affect the aorta wall and the vessels leading from it. Also characteristic are perirenal fibrotic changes spreading in the retroperitoneum. They can cause serious complications - hydronephrosis with all its consequences.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.